{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:53:34Z","timestamp":1755798814366},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,23]]},"DOI":"10.7759\/cureus.27182","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T18:59:35Z","timestamp":1658602775000},"source":"Crossref","is-referenced-by-count":3,"title":["Intranasal Xylitol for the Treatment of COVID-19 in the Outpatient Setting: A Pilot Study"],"prefix":"10.7759","author":[{"given":"Evangelina","family":"Soler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"de Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor I","family":"Cuello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G","family":"Silva-Vetri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoilangel H","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rams\u00e9s G","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed A","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Sanchez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) dashboard. (2022). Accessed. July 23, 2022: https:\/\/covid19.who.int\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2020.52.3.335","article-title":"A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation","volume":"52","author":"Sanchez-Gonzalez MA","year":"2020","unstructured":"Sanchez-Gonzalez MA, Moskowitz D, Issuree PD, Yatzkan G, Rizvi SA, Day K. A Pathophysiological Perspective on COVID-19's Lethal Complication: From Viremia to Hypersensitivity Pneumonitis-like Immune Dysregulation. Infect Chemother. 2020, 52:335-44. 10.3947\/ic.2020.52.3.335","journal-title":"Infect Chemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.140289","article-title":"Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis","volume":"5","author":"Wilson JG","year":"2020","unstructured":"Wilson JG, Simpson LJ, Ferreira AM, et al.. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis. JCI Insight. 2020, 5:10.1172\/jci.insight.140289","journal-title":"JCI Insight"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","volume":"71","author":"Qin C","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, et al.. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020, 71:762-8. 10.1093\/cid\/ciaa248","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00849-0","article-title":"SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury","volume":"6","author":"Wu ML","year":"2021","unstructured":"Wu ML, Liu FL, Sun J, et al.. SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. Signal Transduct Target Ther. 2021, 6:428. 10.1038\/s41392-021-00849-0","journal-title":"Signal Transduct Target Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2009637117","article-title":"Identifying airborne transmission as the dominant route for the spread of COVID-19","volume":"117","author":"Zhang R","year":"2020","unstructured":"Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ. Identifying airborne transmission as the dominant route for the spread of COVID-19. Proc Natl Acad Sci U S A. 2020, 117:14857-63. 10.1073\/pnas.2009637117","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/01455613211002929","article-title":"Effective nasal disinfection as an overlooked strategy in our fight against COVID-19 [IN PRESS]","author":"Ferrer G","year":"2021","unstructured":"Ferrer G, Sanchez-Gonzalez MA. Effective nasal disinfection as an overlooked strategy in our fight against COVID-19 [IN PRESS]. Ear Nose Throat J. 2021, 1455613211002929. 10.1177\/01455613211002929","journal-title":"Ear Nose Throat J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.23.14614-14621.2005","article-title":"ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia","volume":"79","author":"Jia HP","year":"2005","unstructured":"Jia HP, Look DC, Shi L, et al.. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005, 79:14614-21. 10.1128\/JVI.79.23.14614-14621.2005","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming I","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004, 203:631-7. 10.1002\/path.1570","journal-title":"J Pathol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19145-6","article-title":"ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs","volume":"11","author":"Lee IT","year":"2020","unstructured":"Lee IT, Nakayama T, Wu CT, et al.. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs. Nat Commun. 2020, 11:5453. 10.1038\/s41467-020-19145-6","journal-title":"Nat Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","unstructured":"A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020, 20.e192-7. 10.1016\/S1473-3099(20)30483-7","journal-title":"Lancet Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00841-4","article-title":"Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets","volume":"6","author":"Singh DK","year":"2021","unstructured":"Singh DK, Singh B, Ganatra SR, et al.. Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets. Nat Microbiol. 2021, 6:73-86. 10.1038\/s41564-020-00841-4","journal-title":"Nat Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","volume":"75","author":"Zhang JJ","year":"2020","unstructured":"Zhang JJ, Dong X, Cao YY, et al.. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020, 75:1730-41. 10.1111\/all.14238","journal-title":"Allergy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s43168-020-00049-4","article-title":"Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score","volume":"15","author":"Galal I","year":"2021","unstructured":"Galal I, Hussein AA, Amin MT, et al.. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. 2021, 15:10. 10.1186\/s43168-020-00049-4"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11315","article-title":"Potential role of xylitol plus grapefruit seed extract nasal spray solution in COVID- 19: case series","volume":"12","author":"Go CC","year":"2020","unstructured":"Go CC, Pandav K, Sanchez-Gonzalez MA, Ferrer G. Potential role of xylitol plus grapefruit seed extract nasal spray solution in COVID- 19: case series. Cureus. 2020, 12:e11315. 10.7759\/cureus.11315","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.12.02.408575","article-title":"In vitro analysis of the anti-viral potential of nasal spray constituents against SARS-CoV-2 [PREPRINT]","author":"Cannon ML","year":"2020","unstructured":"Cannon ML, Westover JB, Bleher R, Sanchez-Gonzalez MA, Ferrer G. In vitro analysis of the anti-viral potential of nasal spray constituents against SARS-CoV-2 [PREPRINT]. bioRxiv. 2020, 10.1101\/2020.12.02.408575","journal-title":"bioRxiv"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.23812\/21-138-L","article-title":"Hypertonic saline with xylitol and hyaluronate may shorten the viral shedding duration in asymptomatic COVID-19 positive subjects: a pilot study","volume":"35","author":"Ciprandi G","year":"2021","unstructured":"Ciprandi G, La Mantia I, Brunese FP, Varricchio A, Varricchio A. Hypertonic saline with xylitol and hyaluronate may shorten the viral shedding duration in asymptomatic COVID-19 positive subjects: a pilot study. J Biol Regul Homeost Agents. 2021, 35:1151-4. 10.23812\/21-138-L","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13623","article-title":"Effects of short-term xylitol chewing gum on pro-inflammatory cytokines and Streptococcus mutans: A randomised, placebo-controlled trial","volume":"74","author":"Akg\u00fcl \u00d6","year":"2020","unstructured":"Akg\u00fcl \u00d6, Topalo\u011flu Ak A, Zorlu S, \u00d6ner \u00d6zda\u015f D, Uslu M, \u00c7ayirgan D. Effects of short-term xylitol chewing gum on pro-inflammatory cytokines and Streptococcus mutans: A randomised, placebo-controlled trial. Int J Clin Pract. 2020, 74:e13623. 10.1111\/ijcp.13623","journal-title":"Int J Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/lary.22176","article-title":"Xylitol nasal irrigation in the management of chronic rhinosinusitis: a pilot study","volume":"121","author":"Weissman JD","year":"2011","unstructured":"Weissman JD, Fernandez F, Hwang PH. Xylitol nasal irrigation in the management of chronic rhinosinusitis: a pilot study. Laryngoscope. 2011, 121:2468-72. 10.1002\/lary.22176","journal-title":"Laryngoscope"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b15-00773","article-title":"Ameliorating effect of dietary xylitol on human respiratory syncytial virus (hRSV) infection","volume":"39","author":"Xu ML","year":"2016","unstructured":"Xu ML, Wi GR, Kim HJ, Kim HJ. Ameliorating effect of dietary xylitol on human respiratory syncytial virus (hRSV) infection. Biol Pharm Bull. 2016, 39:540-6. 10.1248\/bpb.b15-00773","journal-title":"Biol Pharm Bull"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000163020","article-title":"Acid production from sugars and sugar alcohols by probiotic lactobacilli and bifidobacteria in vitro","volume":"42","author":"Haukioja A","year":"2008","unstructured":"Haukioja A, S\u00f6derling E, Tenovuo J. Acid production from sugars and sugar alcohols by probiotic lactobacilli and bifidobacteria in vitro. Caries Res. 2008, 42:449-53. 10.1159\/000163020","journal-title":"Caries Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2012.702288","article-title":"Xylitol: a review on bioproduction, application, health benefits, and related safety issues","volume":"55","author":"Ur-Rehman S","year":"2015","unstructured":"Ur-Rehman S, Mushtaq Z, Zahoor T, Jamil A, Murtaza MA. Xylitol: a review on bioproduction, application, health benefits, and related safety issues. Crit Rev Food Sci Nutr. 2015, 55:1514-28. 10.1080\/10408398.2012.702288","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602532","article-title":"Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid","volume":"61","author":"Storey D","year":"2007","unstructured":"Storey D, Lee A, Bornet F, Brouns F. Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid. Eur J Clin Nutr. 2007, 61:349-54. 10.1038\/sj.ejcn.1602532","journal-title":"Eur J Clin Nutr"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.2307\/2529712","article-title":"Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial","volume":"31","author":"Pocock SJ","year":"1975","unstructured":"Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975, 31:103-15.","journal-title":"Biometrics"},{"key":"ref25","unstructured":"Protocolo para el Diagn\u00f3stico y Tratamiento del Coronavirus (COVID-19) (Ministerio de Salud P\u00fablica y Asistencia Social) 65 [source in Spanish]. (2021). Accessed. July 23, 2022: https:\/\/repositorio.msp.gob.do\/handle\/123456789\/2270."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01276.x","article-title":"Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines","volume":"62","author":"Bousquet PJ","year":"2007","unstructured":"Bousquet PJ, Combescure C, Neukirch F, Klossek JM, M\u00e9chin H, Daures JP, Bousquet J. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007, 62:367-72. 10.1111\/j.1398-9995.2006.01276.x","journal-title":"Allergy"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2017.03.006","article-title":"Xylitol nasal irrigation in the treatment of chronic rhinosinusitis","volume":"38","author":"Lin L","year":"2017","unstructured":"Lin L, Tang X, Wei J, Dai F, Sun G. Xylitol nasal irrigation in the treatment of chronic rhinosinusitis. Am J Otolaryngol. 2017, 38:383-9. 10.1016\/j.amjoto.2017.03.006","journal-title":"Am J Otolaryngol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1101\/2021.08.16.21262044","article-title":"Rapid initiation of nasal saline irrigation to reduce morbidity and mortality in COVID+ outpatients: a randomized clinical trial compared to a national dataset [PREPRINT}","author":"Baxter AL","year":"2021","unstructured":"Baxter AL, Schwartz KR, Johnson RW, et al.. Rapid initiation of nasal saline irrigation to reduce morbidity and mortality in COVID+ outpatients: a randomized clinical trial compared to a national dataset [PREPRINT}. medRxiv. 2021, 10.1101\/2021.08.16.21262044","journal-title":"medRxiv"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.08.025","article-title":"Corticosteroid protection against COVID- 19: begin with the nose","volume":"9","author":"Lipworth BJ","year":"2021","unstructured":"Lipworth BJ, Chan R, Carr T. Corticosteroid protection against COVID- 19: begin with the nose. J Allergy Clin Immunol Pract. 2021, 9:3941-3. 10.1016\/j.jaip.2021.08.025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.1c00477","article-title":"Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments","volume":"12","author":"Najafloo R","year":"2021","unstructured":"Najafloo R, Majidi J, Asghari A, et al.. Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments. ACS Chem Neurosci. 2021, 12:3795-805. 10.1021\/acschemneuro.1c00477","journal-title":"ACS Chem Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-021-02366-6","article-title":"Olfactory dysfunction among asymptomatic patients with SARS CoV2 infection: a case-control study","volume":"73","author":"Mangal V","year":"2021","unstructured":"Mangal V, Murari T, Vashisht R, et al.. Olfactory dysfunction among asymptomatic patients with SARS CoV2 infection: a case-control study. Indian J Otolaryngol Head Neck Surg. 2021, 73:212-7. 10.1007\/s12070-021-02366-6","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103076","article-title":"Temporal patterns of nasal symptoms in patients with mild severity SARS-CoV-2 infection","volume":"42","author":"Raad RA","year":"2021","unstructured":"Raad RA, Ganti A, Goshtasbi K, et al.. Temporal patterns of nasal symptoms in patients with mild severity SARS-CoV-2 infection. Am J Otolaryngol. 2021, 42:103076. 10.1016\/j.amjoto.2021.103076","journal-title":"Am J Otolaryngol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/nu11081813","article-title":"Xylitol's health benefits beyond dental health: a comprehensive review","volume":"11","author":"Salli K","year":"2019","unstructured":"Salli K, Lehtinen MJ, Tiihonen K, Ouwehand AC. Xylitol's health benefits beyond dental health: a comprehensive review. Nutrients. 2019, 11:1813. 10.3390\/nu11081813","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1999.86.4.1202","article-title":"Hyperosmolar saline induces reflex nasal secretions, evincing neural hyperresponsiveness in allergic rhinitis","volume":"86","author":"Sanico AM","year":"1999","unstructured":"Sanico AM, Philip G, Lai GK, Togias A. Hyperosmolar saline induces reflex nasal secretions, evincing neural hyperresponsiveness in allergic rhinitis. J Appl Physiol (1985). 1999, 86:1202-10. 10.1152\/jappl.1999.86.4.1202","journal-title":"J Appl Physiol (1985)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100176-intranasal-xylitol-for-the-treatment-of-covid-19-in-the-outpatient-setting-a-pilot-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:05Z","timestamp":1707507365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100176-intranasal-xylitol-for-the-treatment-of-covid-19-in-the-outpatient-setting-a-pilot-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.27182","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,23]]}}}